These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 21888924

  • 21. Human cytochrome P450-dependent differential metabolism among three 2α-substituted-1α,25-dihydroxyvitamin D(3) analogs.
    Yasuda K, Ikushiro S, Kamakura M, Takano M, Saito N, Kittaka A, Chen TC, Ohta M, Sakaki T.
    J Steroid Biochem Mol Biol; 2013 Jan; 133():84-92. PubMed ID: 22982757
    [Abstract] [Full Text] [Related]

  • 22. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 23. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells.
    Yang SW, Tsai CY, Pan YC, Yeh CN, Pang JH, Takano M, Kittaka A, Juang HH, Chen TC, Chiang KC.
    Drug Des Devel Ther; 2016 Aug 01; 10():1995-2002. PubMed ID: 27382252
    [Abstract] [Full Text] [Related]

  • 24. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R, Subhashini J, Roy KR, Reddy GS, Robinson M, Uskokovic MR, Venkateswara Reddy G, Reddanna P.
    J Cell Biochem; 2008 Aug 01; 104(5):1832-42. PubMed ID: 18348265
    [Abstract] [Full Text] [Related]

  • 25. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 26. 1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Metastasis After VEGF-A Stimulation.
    Chiang KC, Yeh CN, Pang JS, Hsu JT, Yeh TS, Chen LW, Kuo SF, Takano M, Chen TC, Kittaka A, Hsieh PJ, Juang HH.
    Anticancer Res; 2017 Nov 01; 37(11):6215-6221. PubMed ID: 29061804
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of C-2-substituted 19-nor-1alpha,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer.
    Chen TC, Persons KS, Zheng S, Mathieu J, Holick MF, Lee YF, Bao B, Arai MA, Kittaka A.
    J Steroid Biochem Mol Biol; 2007 Mar 01; 103(3-5):717-20. PubMed ID: 17207993
    [Abstract] [Full Text] [Related]

  • 28. 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines.
    Moffatt KA, Johannes WU, Miller GJ.
    Clin Cancer Res; 1999 Mar 01; 5(3):695-703. PubMed ID: 10100724
    [Abstract] [Full Text] [Related]

  • 29. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
    Baiz D, Pozzato G, Dapas B, Farra R, Scaggiante B, Grassi M, Uxa L, Giansante C, Zennaro C, Guarnieri G, Grassi G.
    Biochimie; 2009 Mar 01; 91(3):373-82. PubMed ID: 19041685
    [Abstract] [Full Text] [Related]

  • 30. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells.
    Fernandez-Garcia NI, Palmer HG, Garcia M, Gonzalez-Martin A, del Rio M, Barettino D, Volpert O, Muñoz A, Jimenez B.
    Oncogene; 2005 Sep 29; 24(43):6533-44. PubMed ID: 16007183
    [Abstract] [Full Text] [Related]

  • 31. MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.
    Chiang KC, Yeh TS, Huang CC, Chang YC, Juang HH, Cheng CT, Pang JS, Hsu JT, Takano M, Chen TC, Kittaka A, Hsiao M, Yeh CN.
    Sci Rep; 2017 Mar 03; 7():43773. PubMed ID: 28256614
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Growth inhibition of carcinogen-transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1alpha-hydroxyvitamin D5.
    Hussain-Hakimjee EA, Peng X, Mehta RR, Mehta RG.
    Carcinogenesis; 2006 Mar 03; 27(3):551-9. PubMed ID: 16195238
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A.
    Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699
    [Abstract] [Full Text] [Related]

  • 38. New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase.
    Bini F, Frati A, Garcia-Gil M, Battistini C, Granado M, Martinesi M, Mainardi M, Vannini E, Luzzati F, Caleo M, Peretto P, Gomez-Muñoz A, Meacci E.
    Neuropharmacology; 2012 Sep 15; 63(4):524-37. PubMed ID: 22579669
    [Abstract] [Full Text] [Related]

  • 39. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
    Nakagawa K, Kawaura A, Kato S, Takeda E, Okano T.
    Carcinogenesis; 2005 Feb 15; 26(2):429-40. PubMed ID: 15539405
    [Abstract] [Full Text] [Related]

  • 40. Induction of apoptosis and inhibition of prostate and breast cancer growth by BGP-15, a new calcipotriene-derived vitamin D3 analog.
    Berkovich L, Ben-Shabat S, Sintov AC.
    Anticancer Drugs; 2010 Jul 15; 21(6):609-18. PubMed ID: 20335794
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.